Abstract
The syntheses of some new zinc(II), palladium(II), platinum(II), ruthenium(II), rhodium(III) and silver(I) complexes of kojic acid (Hka) in both the absence and the presence of N,N- (2,2′-bipyridyl) and P- (triphenylphosphine) ligands are reported. The X-ray crystal structure of the mixed-ligand complex, [Ag(ka)(PPh3)], has been determined. It has been crystallized in a monoclinic lattice with space group symmetry P21/n. The molecular structures of the complexes are discussed on the basis of their IR, NMR (1H, 13C, 31P), UV-Vis, and EI and maldi-mass spectra, elemental analyses, molar conductivities and TGA behaviour. Kojic acid coordinates to the central metal ions in a mono-negative bidentate fashion through the carbonyl O- and the deprotonated ring hydroxy-O atoms. The in vitro anticancer activities of several of the complexes have been examined against the human ovarian cancer (VC-8-BRCA & VC-8) cell lines. The IC50 values for cell growth proliferation of [Ag(ka)(PPh3)] are 8.80 and 8.87 μM, respectively. The corresponding IC50 values for cisplatin are 9.12 and 10.07 μM. The DNA-binding properties of some of the complexes have been studied using UV-vis spectroscopy. The results indicate that the complexes may undergo intercalative CT-DNA binding in view of their hypochromism. The binding constants (Kb) of the complexes with CT-DNA show low-to-moderate binding abilities, which may result from steric hindrance around the metal ions from the primary chelate (Hka) or the bulky secondary (bpy, PPh3) moieties.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.